際華集團(601718.SH):共11户子公司參與醫用防護服生產 日產能約11萬套
格隆匯2月26日丨際華集團(601718.SH)公佈,截止本公告日,公司共有11户子公司參與醫用防護服及隔離服生產,醫用防護服及隔離服日產能約為11萬套,累計產出醫用防護服及隔離服共計約114萬套。
截止本公告日,公司共有4户子公司被列為國家臨時收儲重點生產企業,分別是際華三五零二職業裝有限公司、南京際華三五二一特種裝備有限公司、際華三五三四製衣有限公司、際華三五四三針織服飾有限公司。
公司目前主要從事職業裝、職業鞋靴、皮革皮鞋、紡織印染、防護裝具等軍品、民品的生產和銷售業務,開展防護服生產業務,並非公司主營業務,主要為履行社會責任、支持國家疫情防控工作,不以盈利為主要目的。
公司防護服的生產由現有產能轉產以及新增部分產能實現,生產產品由政府統籌安排並指定價格。業務規模和可持續性受疫情變化的影響,存在較大不確定性。對公司經營業績影響暫時無法確定。
近期公司股價受“防疫概念”影響,短期波動幅度較大,股票交易成交量和換手率較前期明顯放大。公司提請廣大投資者理性投資,注意二級市場交易風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.